SPRY 241220 17.50P (SPRY241220P17500) Stock Options, News & Quotes

US OptionsDetailed Quotes

SPRY241220P17500

Watchlist

3.30
0.000.00%

15min DelayClose Dec 13 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Ars Pharmaceuticals Insider Sold Shares Worth $657,625, According to a Recent SEC Filing
MT NewswiresDec 12 17:47 ET
ARS Pharmaceuticals Files for Approval of Neffy in China, Japan and Australia
TipRanksDec 12 14:40 ET
Express News | ARS Pharmaceuticals Files For Approval Of Neffy In China, Japan And Australia
BenzingaDec 12 14:35 ET
Express News | Form 144 | ARS Pharmaceuticals(SPRY.US) Officer Proposes to Sell 4.02 Million in Common Stocks
Moomoo NewsDec 10 11:20 ET
ARS Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)
SECDec 6 16:10 ET · Announcements
Insider Sale: Director at $SPRY (SPRY) Sells 14,772 Shares
Quiver QuantitativeDec 4 21:45 ET

Comments

Green Dragon 2024

Nov 11 10:40

Additional info…

$ARS Pharmaceuticals (SPRY.US)$ comments from ALK CEO and sales projection. 🍾

Jaguar8

Nov 11 06:09

NEWS

$ARS Pharmaceuticals (SPRY.US)$
ARS Pharmaceuticals Announces Exclusive Agreement with Global Allergy Leader ALK to Commercialize neffy® in Europe, Canada and Other Geographies Outside the United States
Agreement leverages ALK's global footprint in developing and commercializing innovative allergy products
ARS Pharma to receive an upfront cash payment of $145 million, with total deal consideration of up to $465 million plus double-digit royalties on net sales
ARS Pharma retains all U.S. rig...

Green Dragon 2024

Oct 24 10:48

News…

$ARS Pharmaceuticals (SPRY.US)$ Showcases Intranasal Epinephrine Data At 2024 American College Of Allergy, Asthma & Immunology Annual Scientific Meeting, Friday October 25.

Green Dragon 2024

Oct 23 04:33

Increase in shares…

$ARS Pharmaceuticals (SPRY.US)$

Green Dragon 2024

Oct 23 04:20

End to Pfizer monopoly…

$ARS Pharmaceuticals (SPRY.US)$ soon SPRY will end the monopoly.